Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in St Denis – page 114

3 437 clinical trials in St Denis, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
St Denis at a glance
3 437
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 437 trials in St Denis

Open in trial search

Myelodysplastic syndrome

Not yet recruiting

Study of Bexmarilimab with Azacitidine versus Placebo with Azacitidine in Treatment‑Naïve Higher‑Risk Myelodysplastic Syndrome Patients

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bexmarilimab
  • Sponsor:Faron Pharmaceuticals Oy

Safety and Efficacy of GSK5764227 with Abiraterone Acetate and Enzalutamide in Metastatic Castration‑Resistant Prostate Cancer Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Glaxosmithkline Research & Development Limited

Arthroscopy

Not yet recruiting

Study on the effectiveness of dexamethasone and chloroprocaine in extending the effects of spinal anesthesia for patients undergoing knee arthroscopy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Medico Chirurgical Ambroise Pare Hartmann

Study of morphine to relieve shortness of breath in patients with amyotrophic lateral sclerosis who have breathing problems

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Morphine Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris

Transitional cell carcinoma

Not yet recruiting

Neoadjuvant Study of Avelumab with Gemcitabine and Cisplatin versus Chemotherapy Alone in Patients with High‑Grade Localized Upper Tract Urothelial Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Centre Hospitalier Universitaire De Nimes

Ravulizumab versus plasma exchange for acute neuromyelitis optica attacks: a randomized trial in patients with first or relapsed episodes

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Efficacy and Safety of Sodium Valproate Added to Standard Therapy in Patients with Stable Pulmonary Arterial Hypertension – Phase 2b Randomized Study

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Valproate
  • Sponsor:Cereno Scientific AB

Antiphospholipid syndrome

Not yet recruiting

Stopping warfarin sodium, fluindione, or acenocoumarol in low‑risk thrombotic antiphospholipid syndrome patients after antibody loss

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Assistance Publique Hopitaux De Paris

Diabetic retinal oedema

Not yet recruiting

Efficacy and Safety of Intravitreal MK-8748 Compared with Aflibercept in Adults with Diabetic Macular Edema

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure

Not yet recruiting

Efficacy and Safety of Fixed‑Dose Combination of Dapagliflozin, Bisoprolol Fumarate, and Eplerenone vs Usual Care in Hospitalized Acute Heart Failure Patients

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Bronchiectasis

Not yet recruiting

Efficacy and safety of galvokimig in adults with non‑cystic fibrosis bronchiectasis: a randomized, double‑blind, placebo‑controlled phase 2 trial

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Galvokimig
  • Sponsor:UCB Biopharma

Chronic lymphocytic leukaemia+1

Not yet recruiting

Phase II Study of Zanubrutinib in Elderly, Treatment‑Naïve Patients with Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Zanubrutinib
  • Sponsor:LYSARC

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in St Denis

What the registry says about research in the country

01 Infectious and Respiratory Diseases

Clinical studies focusing on Chikungunya vaccination effectiveness in vulnerable populations, alongside research into ventilator-associated pneumonia treatment strategies in intensive care settings.

  • Viral infections and prevention
  • Respiratory complications
  • Antimicrobial stewardship

Research includes evaluation of treatments for Herpes Simplex Virus Encephalitis and innovative approaches to respiratory conditions.

02 Oncology Studies

Innovative research into treatment protocols for colorectal cancer and ampullary adenocarcinoma, exploring new therapeutic combinations and surgical approaches.

  • Advanced colorectal treatments
  • Neoadjuvant chemotherapy
  • Surgical outcomes

Studies focus on improving survival rates and treatment efficacy for various cancer types.

03 Autoimmune and Inflammatory Conditions

Research examining treatments for Kawasaki disease, vitiligo, and sarcoidosis, testing innovative therapeutic approaches and combination treatments.

  • Immunological responses
  • Novel treatment combinations
  • Disease management strategies

Investigations into the effectiveness of various immunomodulatory therapies and treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.